Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blackhawk Growth Corp C.BLR

Alternate Symbol(s):  C.BLR.WT | BLRZF

Financial Services Asset Management
Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the United States.


CSE:BLR - Post by User

Blackhawk Growth Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Post by Loonyon Feb 18, 2024 10:06pm
104 Views
Post# 35887174

Medigen as Effective as Moderna/Pfizer.

Medigen as Effective as Moderna/Pfizer.Medigen investment

https://www.facebook.com/blackhawkgrowth/photos/181118566922520/?locale=ms_MY&paipv=0&eav=AfY1DfT3UBhVJmKdEhbHxC8TRW1U6vS-zZKoBhqLEstXYZuf-9UP3QFxWONEWj5zTS8&_rdr


https://focustaiwan.tw/sci-tech/202402020014

Taipei, Feb. 2 (CNA) Research conducted by Taiwan's Centers for Disease Control (CDC) showing the locally-produced Medigen COVID-19 vaccine to be as effective as those from Moderna and Pfizer BioNTech is set to be published in a U.S. medical journal.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities